We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Rapid Sepsis Test Uses Magnetic Nanoparticles to Detect Bacterial Pathogens

By LabMedica International staff writers
Posted on 24 Aug 2023
Print article
Image: Magnetic nanoparticles (red) bind specifically to the spherical bacteria (yellow) (Photo courtesy of Empa)
Image: Magnetic nanoparticles (red) bind specifically to the spherical bacteria (yellow) (Photo courtesy of Empa)

When it comes to life-threatening blood poisoning caused by staphylococcus bacteria, quick identification of the bacteria in the bloodstream is vital to begin life-saving treatment. This urgency stems from the fact that staphylococcal sepsis results in fatality for up to 40% of cases. The infection, triggered by spherical bacteria, might initially manifest as a local skin ailment or pneumonia. However, when staphylococci infiltrate the bloodstream during sepsis, severe complications can emerge. In such critical scenarios, prompt identification of pathogens and selection of suitable antibiotics are vital. This is especially crucial as Staphylococcus aureus strains can exhibit resistance to multiple antibiotics. Researchers have now developed "sepsis sensors" using magnetic nanoparticles that enable rapid detection of bacterial pathogens and identification of appropriate antibiotic candidates.

Researchers at Empa (Dübendorf, Switzerland), along with their colleagues from ETH Zurich (Zürich, Switzerland), looked for a way to bypass the lengthy intermediate step of first cultivating the bacteria in a blood sample for a diagnostic procedure. They developed a method utilizing magnetic nanoparticles that are capable of binding to staphylococci. Consequently, these bacteria can be identified through the application of a magnetic field. Subsequently, antibiotic sensitivity is assessed using a chemiluminescence technique. If antibiotic-resistant bacteria are present in the sample, it emits light. Conversely, if the bacteria can be eradicated with antibiotics, the reaction vessel remains dark.

Another problematic bacterial entity is Pseudomonas aeruginosa, a rod-shaped bacterium capable of causing various illnesses, including urinary tract infections via catheterization during hospital stays. Such infections can develop into sepsis, and these pathogens are often resistant to numerous antibiotics. In such cases, magnetic nanoparticles offer the distinct advantage of versatility. The approach can be customized for different bacteria types, similar to a modular system. This adaptability enabled the researchers to design a rapid "sepsis sensor" leveraging magnetic nanoparticles. In samples containing synthetic urine, this method reliably identified bacterial species and gauged potential antibiotic resistance through chemiluminescence reactions. So far, the researchers have assessed their magnetic nanoparticle toolkit for sepsis and urinary tract infections using laboratory samples. In the coming phase, the team plans to validate the sepsis tests alongside their clinical partners by analyzing patient samples.

"All in all, the sepsis test takes around three hours – compared to several days for a classic cultivation of bacterial cultures," said Empa researcher Fei Pan.

Related Links:
Empa 
ETH Zurich 

New
Platinum Supplier
Automatic Nucleic Acid Workstation
Pana9600X
New
Gold Supplier
PCR Microplate
SAPPHIRE MICROPLATE
New
cTnI Test
OnSite Troponin I Combo Rapid Test
New
Pregnancy Test
Viola

Print article
GLOBETECH PUBLISHING LLC

Channels

Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more

Molecular Diagnostics

view channel
Image: A CRISPR technology-based diagnostic test detects MPXV in clinical samples with acute precision (Photo courtesy of 123RF)

Powerful Diagnostic Tool Accurately Detects Monkeypox Virus Faster Than Any Method

At present, testing for the monkeypox virus (MPXV) is done mainly in centralized labs, and it can take days to get results due to location and logistical issues. Now, researchers have leveraged cutting-edge... Read more

Hematology

view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more

Immunology

view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more

Pathology

view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more

Technology

view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more

Industry

view channel
Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.